CIK 0001609809 · Non-accelerated filer<br>Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 274326290
- Phone
- 617 945 9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,230
- in 4 filings, $2K under 10b5-1 plans
Net −$2,230. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-15 | Henn Matthew R. See Remarks | Option exercise 10b5-1 | +2,812 | 66,248 | ||
| 2024-05-15 | Henn Matthew R. See Remarks | Sale 10b5-1 | −891 | $0.94 | $838 | 65,357 |
| 2024-05-15 | Henn Matthew R. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,812 | 30,938 | ||
| 2024-05-15 | Ege David S. See Remarks | Option exercise 10b5-1 | +2,968 | 76,824 | ||
| 2024-05-15 | Ege David S. See Remarks | Sale 10b5-1 | −1,090 | $0.94 | $1K | 75,734 |
| 2024-05-15 | Ege David S. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,968 | 32,657 | ||
| 2024-05-15 | DesRosier Thomas Chief Legal Officer and EVP | Option exercise 10b5-1 | +2,656 | 123,233 | ||
| 2024-05-15 | DesRosier Thomas Chief Legal Officer and EVP | Sale 10b5-1 | −843 | $0.94 | $792 | 122,390 |
| 2024-05-15 | DesRosier Thomas Chief Legal Officer and EVP | Option exercise · Restricted Stock Units 10b5-1 | −2,656 | 29,219 | ||
| 2024-04-04 | Biondi Paul Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2024-04-04 | Ausiello Dennis A Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-04-04 | Fraser Claire Director | Grant or award · Stock Option (right to buy | +60,000 | 60,000 | ||
| 2024-04-04 | Graves Kurt Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-04-04 | Berenson Stephen Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 |
Page 13 of 13 · 254 trades